– USA, NY – K Health, the data-driven digital primary care solution, today announced the closing of a $132M Series E round of funding round led by GGV Capital and Valor Equity Partners with participation from Kaiser Permanente pension fund and LTS Investments, the investment offices of Lemann, Telles, and Sicupira, behind 3G Capital.
Concurrent with the financing, Antonio Gracias, Founder and CEO at Valor Equity Partners, sitting on the boards of SpaceX and Tesla, will join the board alongside Hans Tung, Managing Partner at GGV Capital. Vivek Pattipati, Partner at Valor, will join as an observer.
Additional investors include 14W, Max Ventures, Pico Partners, Marcy Venture Partners, Primary Venture Partners, and BoxGroup.
“The world needs a new archetype for health care, and K Health’s data, world-class doctors, and team are resolute enough to deliver this,” said Hans Tung, Managing Partner at GGV Capital. “GGV backs companies with the potential to serve the greatest number of people, and by solving the healthcare inequities of access and affordability, K Health is one of the most impactful consumer health companies constructing the future of care for us all.”
“It’s impressive to see the pace at which K Health is expanding to translate decades of rich data and doctor experience to meet families where they are,” said Gracias, Valor Equity Partners’ Founder, and CEO. “We believe that K Health will be game-changing for families while also improving the broader health care system to enable faster, more efficient, and more seamless resolution of primary care concerns.”
“K Health is changing the equation of access to high-quality medicine,” said Allon Bloch, CEO & co-founder of K Health. “Our system opens access to the best doctors at a fraction of the cost and without the wait. This new funding and expansion to care for the whole family give more people the break they need today.”
As part of its mission toward building a global system for better medicine and access to treatment, K Health announced a collaboration with Mayo Clinic through the Mayo Clinic Platform in November 2020. The joint work focuses on improving and accelerating the deployment of virtual care models to improve health outcomes. The company also has a partnership with Maccabi Healthcare Services, Israel’s second-largest HMO with 2.4 million members; as well as Anthem, to offer K Health to its 43 million members.
About K Health
K Health, headquartered in New York, is the digital primary care service on a mission to connect the world’s health data to give people the fastest, smartest, most convenient solution to getting remote treatment whenever they need it. K Health allows users to understand how doctors diagnose and treat similar people with similar symptoms and conditions for free, chat with a doctor for less than a copay, and retain a history of their own medical records. K Health has created a data-driven platform that consolidates the knowledge of thousands of doctors and billions of clinical data insights to help people seek answers or treatment without hesitation. K Health covers almost all primary care conditions as well as anxiety and depression with customizable treatment plans.
Frequently the #1 downloaded app in the App Store’s medical category, K is available in all 50 states, and K Primary Care, the option to chat with a doctor, is available in 49 states, covering 300 million people. K Health has also been peer-reviewed in research journals, including the Journal of Medical Internet Research.
For more information: https://khealth.ai/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.